Serum Ferritin Levels and Transferrin Saturation in Men with Prostate Cancer

Journal of the National Medical Association

Volumn 96, Issue 5, 2004, Pages 641-649

  Kuvibidila, Solo R ^a,b,c   Gauthier, Tony ^a,b   Rayford, Walter ^a,b  

^a LA State Univ Hlth Sci Ctr ^*

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

Iron deficiency; Iron overload; Prostate cancer; Serum ferritin; Transferrin saturation

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON OVERLOAD; LIVER CANCER; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; PREVALENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TRANSFERRIN;

EID: 2342439434     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. The Prostate. 1999;38:237-245.
2. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995;87:652-661.
3. Jemal A, Murray T, Samuels A, et al. Cancer Statistics, 2003: Further decrease in mortality rate, and increase in persons living with cancer. CA Cancer J Clin. 2003;53:5-26.
4. Levine RL, Wilchinsky M. Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites. J Urol. 1978; 121:761-762.
5. Hayes RB, Ziegler GR, Gridley G, et al. Dietary factors and risk for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8:25-34.
6. Aprikian AG, Bazinet M, Plante, et al. Family history and risk of prostate carcinoma in a high-risk group of urological patients. J Urol. 1995;154:404-406.
7. Abdalla I, Ray P, Ray V, et al. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer. Am J Clin Oncol. 1999;22:537-541.
8. Thompson IM, Coltman CA, Crowley J. Chemoprevention of prostate cancer: the prostate cancer prevention trial. The Prostate. 1997;33:217-221.
9. Liang JY, Liu YY, Zou J, et al. Inhibitory effect of zinc on human prostatic carcinoma cell growth. The Prostate. 1999;40: 200-207.
10. Hann H-WL, Kim CY, London WT, et al. Increased serum ferritin in chronic liver disease: a risk factor for hepatocellular carcinoma. Int J Cancer. 1989;43:376-379.
11. Powell L, Halliday JW. Serum ferritin levels and hepatocellular carcinoma: the cart or the horse? Hepatology. 1990;11: 706-707.
12. Walker AP, Segal I. Iron overload in Sub-Saharan Africa: to what extent is it a public health problem? Br J Nutr. 1999; 81:427-434.
13. Wurzelmann JI, Silver A, Schreinemachers, et al. Iron intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:503-507.
14. Stevens GR, Graubard BI, Micozzi MS, et al. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer. 1994;56:364-369.
15. Sawa T, Akaike T, Kida K, et al. Lipid peroxyl radicals from oxidized oils and heme-iron: implication of a high-fat diet in colon carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1998; 7:1007-1012.
16. Hann H-WL, Stahlhut MW, Hann LC. Effect of iron and deferxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology. 1990;11:566-569.
17. Lederman HM, Cohen A, Lee JW, et al. Deferoxamine: a reversal S-phase inhibitor of human lymphocyte proliferation. Blood. 1984;64:748-753.
18. Haq RU, Wereley JP, Chitambar CR. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp Hematol. 1995;23:428-432.
19. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and acute liver diseases. Gastroenterology. 1975;68:525-533.
20. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290: 1213-1216.
21. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973-976.
22. Cook DJ, Skikne BS. Iron deficiency: definition and diagnosis. J Internal Med. 1989;226:349-355.
23. Mancini G, Carbinaia AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965;2:2345-2354.
24. Engler R. Bases méthodologiques: protéines à réaction inflammatoire. Notion da profil protéique. Pédiatrie. 1984;39:339-344.
25. Munro HM, Visitainer MA, Page EB (editors). Statistical Methods for Health Care Research. JB Lippincott, Philadelphia; 1993; pp. 57-58 and 110-127.
26. Matzner Y, Konji AM, Hershko C. Serum ferritin in hematologic malignancies. Am J Hematol. 1980;9:13-22.
27. Knekt P, Reunanen A, Takkunen H, et al. Body iron stores and risk of cancer. Intern J Cancer. 1994;56:379-382.
28. Zacharski LR, Ornestein DL, Woloshin S, et al. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J. 2000;140:98-104.
29. Custer ME, Finch CA, Sobel RE, et al. Population norms for serum ferritin. J Lab Clin Med. 1995;126:88-94.
30. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1986;246:501-514.
31. Siergers CP, Bumann D, Baretton G, et al. Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice. Cancer Letters. 1988;41:251-256.
32. Spear AT, Sherman AR. Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats. J Nutr. 1992;122:46-55.
33. Hann H-WL, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res. 1988;48:4168-4170.
34. Stevens RG, Jones DY, Micozzi MS, et al. Body iron stores and the risk of cancer. N Engl J Med. 1988;319:1047-1052.
35. Nomura A, Chou PH, Stemmermann GN. Association of serum ferritin levels with risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 1992;1:547-550.
36. Akiba S, Neriishi K, Blot WJ, et al. Serum ferritin and stomach cancer risk among Japanese population. Cancer. 1991; 67:1707-1712.